These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15341444)

  • 1. Bisphosphonate use in metastatic breast cancer: an audit assessing implementation of the British Association of Surgical Oncologists' guidelines.
    Abson C; James R; Smith C
    Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):379. PubMed ID: 15341444
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting skeletal complications in metastatic breast cancer raises challenges.
    Van Poznak C
    Breast Cancer Res Treat; 2010 Oct; 123(3):781-3. PubMed ID: 20690039
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacological management of skeletal-related events from metastatic tumors.
    Hitron A; Adams V
    Orthopedics; 2009 Mar; 32(3):188. PubMed ID: 19309055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metastatic bone disease in breast cancer: bisphosphonates.
    Diel IJ; Solomayer EF; Bastert G
    Clin Breast Cancer; 2000 Apr; 1(1):43-51. PubMed ID: 11899389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progress in treatment of metastatic tumors in the bone by bisphosphonate].
    Dong M; Chen XP; Feng FY
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):801-3. PubMed ID: 18396633
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S
    Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates.
    Body JJ
    Eur J Cancer; 1998 Feb; 34(2):263-9. PubMed ID: 9741331
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of bisphosphonates for bone metastasis in breast cancer].
    Yamada K; Kohno N
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():352-5. PubMed ID: 18161130
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationale for the use of bisphosphonates in breast cancer.
    Kanis JA
    Acta Oncol; 1996; 35 Suppl 5():61-7. PubMed ID: 9142969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bisphosphonate treatment against breast cancer with bone metastases].
    Kohno N
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():575-81. PubMed ID: 17682213
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.
    Hortobagyi GN; Theriault RL; Porter L; Blayney D; Lipton A; Sinoff C; Wheeler H; Simeone JF; Seaman J; Knight RD
    N Engl J Med; 1996 Dec; 335(24):1785-91. PubMed ID: 8965890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V
    Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bisphosphonates in the therapy of cancer patients].
    Jantunen E; Kumpulainen E
    Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ
    Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biphosphonates in oncology].
    Khosravi Shahi P; Díaz Muñoz de la Espada V
    An Med Interna; 2005 Nov; 22(11):544-7. PubMed ID: 16454591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.
    Heatley S
    Int J Palliat Nurs; 2001 Jun; 7(6):301-2, 304-7. PubMed ID: 12066026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis.
    Ding X; Fan Y; Ma F; Li Q; Wang J; Zhang P; Yuan P; Xu B
    Breast; 2012 Aug; 21(4):544-9. PubMed ID: 22627092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer: bisphosphonate therapy for metastatic bone disease.
    Body JJ
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6258s-6263s. PubMed ID: 17062710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone metastases and hypercalcemia in cancer].
    Body JJ; Glibert F; Nejai S; Borkowski A
    Rev Med Liege; 1988 Mar; 43(6):190-3. PubMed ID: 3375643
    [No Abstract]   [Full Text] [Related]  

  • 20. Should all breast cancer patients with symptomatic bone metastasis be treated with bisphosphonates? The case against.
    Hoskin PJ
    Clin Oncol (R Coll Radiol); 2004 Apr; 16(2):112-4. PubMed ID: 15074733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.